Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Oxcarbazepine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD004857Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 20 octubre 2003see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Trastornos mentales comunes

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Akshya Vasudev

    Correspondencia a: Castleside Offices, Centre for Health of the Elderly, Newcastle Upon Tyne, UK

    [email protected]

  • Karine Macritchie

    Department of Psychiatry, University of British Columbia, Vancouver, Canada

  • Stuart Watson

    Department of Psychiatry, Leazes Wing, Royal Victoria Infirmary, Newcastle‐upon‐Tyne, UK

  • John Geddes

    Department of Psychiatry, University of Oxford, Oxford, UK

  • Allan H Young

    Department of Psychiatry, University of British Columbia, Vancouver, Canada

Contributions of authors

Dr A Vasudev: performed literature search, data extractions, data analysis, selection of trials, co wrote the protocol and drafted the review
Dr KAN Macritchie: data extraction, selection of trials, drafted the review
Dr S Watson: Quality assessment, data extraction, selection of trials, drafted the review
Prof AH Young: Quality assessment, commented on the protocol and contributed to drafting of the review
Prof JR Geddes: commented on the protocol and contributed to drafting of the review

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Stanley Medical Research Institute, USA.

Declarations of interest

None of the reviewers is an employee of or has shares in a pharmaceutical company. Professor Young, Dr Watson and Dr Macritchie have spoken at meetings and attended conferences sponsored by various pharmaceutical companies and have participated in trials sponsored by pharmaceutical companies. JG has received research funding and support from Sanofi‐Aventis and GlaxoSmithKline and is currently in discussion with several other companies that manufacture SSRIs about collaboration on planned independent trials and systematic reviews.

Version history

Published

Title

Stage

Authors

Version

2011 Dec 07

Oxcarbazepine for acute affective episodes in bipolar disorder

Review

Akshya Vasudev, Karine Macritchie, Kamini Vasudev, Stuart Watson, John Geddes, Allan H Young

https://doi.org/10.1002/14651858.CD004857.pub2

2003 Oct 20

Oxcarbazepine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability

Protocol

Akshya Vasudev, Karine Macritchie, Stuart Watson, John Geddes, Allan H Young

https://doi.org/10.1002/14651858.CD004857

Notes

We anticipate the first draft of the review to be submitted by 31st December 2007.

Keywords

MeSH